This inventor holds 1 USPTO granted patent. Top assignee: Savyon Diagnostics Ltd.. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Bella Ohana: Innovator in Chlamydia Diagnostics
Introduction
Bella Ohana is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of diagnostics, particularly in the detection of Chlamydia trachomatis. Her innovative work has led to the development of specific peptides that enhance diagnostic assays.
Latest Patents
Bella Ohana holds 1 patent for her invention titled "Chlamydia trachomatis specific peptides and their use in diagnostic assays." This patent discloses peptides or a mixture of peptides, or analogs derived from the variable domains of the immunodominant major outer membrane protein (MOMP). The peptides are characterized by their specificity to anti-MOMP antibodies, ensuring they do not cross-react with antibodies from other Chlamydia species. Specific peptides are described (SEQ ID Nos. 1 to 8) along with their analogs, which maintain similar biological activity.
Career Highlights
Bella is currently associated with Savyon Diagnostics Ltd., where she continues to advance her research in diagnostic technologies. Her work is pivotal in improving the accuracy and reliability of Chlamydia testing, which is crucial for public health.
Collaborations
[Section skipped due to space constraints.]
Conclusion
Bella Ohana's contributions to the field of diagnostics, particularly through her innovative patent, highlight her role as a leading inventor in the medical technology sector. Her work continues to impact the way Chlamydia infections are diagnosed and managed.